Pharming B.V.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Pharming B.V.
Live alerts from global media, monitored by Business Radar
2024-09-26 (iex.nl)
Pharming may bring Joenja to the British market
Pharming has been given the green light to also bring Joenja to the British market. A welcome boost for the Leiden group. <br><br>And that's three: after the US and Israel, the UK has also approved Pharming's Joenja (leniolisib). That will be it...
Read more
2024-09-26 (bnr.nl)
Leiden biotech company markets medicine for a very rare disease
Joenja works against the rare immune disease APDS. One and a half people out of every million people will be affected and the prospects of the diagnosis are…
Read more
2024-05-23 (veb.net)
Pharming sticks to strategy despite frustration about share price
A top executive complaining about the low share price. Are investors so stupid that they do not understand the strategy of biotech company Pharming, is communication faltering, or does the market distrust the great plans?
Read more
2024-01-11 (beleggersbelangen.nl)
Readers Competition | Especially Nasdaq popular for 2024
The annual readers' competition of Beleggers Belangen has once again produced a large number of well-known and lesser-known names for 2024.
Read more